Transgenic N-myc mouse model for indolent B cell lymphoma: Tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors

Oncogene

Volumn 17, Issue 16, 1998, Pages 2073-2085

  Sheppard, Rachel D ^a,b   Samant, Sadhana A ^b   Rosenberg, Marjorie ^a,c   Silver, Lee M ^a   Cole, Michael D ^a  

^a PRINCETON UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Indolent B cell lymphoma; N myc; Retroviral insertion; Tumor progression

Indexed keywords

LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; PROTEIN BCL 2;

ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; CYTOARCHITECTURE; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; RETROVIRUS; TRANSGENIC MOUSE; TUMOR GROWTH;

EID: 0032558735     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202125     Document Type: Article

References (96)

1. Adams JM and Cory S. (1991). Science, 254, 1161-1167.
2. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD and Brinster RL. (1985). Nature, 318, 533-538.
3. Alexander WS, Bernard O, Cory S and Adams JM. (1989). Oncogene, 4, 575-581.
4. Berns A, Breuer M, Verbeek S and van Lohuizen M. (1989). Int. J. Cancer Suppl., 4, 22-45.
5. Berns A. (1991). J. Cell. Biochem., 47, 130-135.
6. Breuer M, Wientjens E, Verbeek S, Slebos R and Berns A. (1991). Cancer Res., 51, 958-963.
7. Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM. (1984). Science, 224, 1121-1124.
8. Chomomeznski P and Saechi N. (1987). Anal. Biochem., 162, 156-159.
9. Cleveland JL, Hansen HW, Bister K, Frederickson TN, Morse III H, Ihle JN and Rapp UR. (1986). J. Cell. Biochem., 30, 195-218.
10. Cole MD. (1986). Ann. Rev. Gen., 20, 361-384.
11. Collum RG and Alt FW. (1990). Cancer Cells. 2, 69-75.
12. Cory S and Adams JM. (1988). Ann. Rev. Immunol., 6, 25-48.
13. Cuypers HT, Selten G, Quint W, Zilstra M, Maadag ER, Boelens W, van Wezenbeek P, Melief C and Berns A. (1984). Cell, 31, 141-150.
14. Dildrop R, Ma A, Zimmerman K, Hsu E, Tesfaye A, DePinho R and Alt FW. (1989). EMBO J., 8, 1121-1128.
15. Doleetti R, Rizzo S. Viel A, Maestro R, De Re V, Feriotto G and Boiocchi M. (1989). Oncogene, 4, 1009-1014.
16. Finke J, Slanina J, Lange W and Dolken G. (1993). J. Clin. Oncol., 11, 1668-1673.
17. Frizzera G, Sakurari M, Notohara K and Konishi H. (1991). Am. J. Clin. Path., 95, 684-691.
18. Gillies SD, Morrison SL, Oi VT and Tonegawa S. (1983). Cell, 33, 717-728.
19. Goates JJ, Kamel OW, LeBrun DP, Benharroch D and Dorfman RF. (1994). Am. J. Surg. Path., 18, 37-47.
20. Gray DA. (1991). Cancer Invest., 9, 295-304.
21. Hamilton MS, Barker HF, Ball J, Drew M, Abbot SD and Franklin IM. (1991). Leukemia, 5, 768-771.
22. Harris AW, Pinkert CA, Crawford M, Langdon WY, Brinster RL and Adams JM. (1988). J. Exp. Med., 167, 353-371.
23. Harris NL and Ferry JA. (1992). Neoplastic Hematopathology, DM Knowles (ed.). William and Wilkins Co, pp. 645-674.
24. Haupt Y, Alexander WS, Barri G, Klinken SP and Adams JM. (1991). Cell, 65, 753-763.
25. Haupt Y, Bath ML, Harris AW and Adams JM. (1993). Oncogene, 8, 3161-3164.
26. Hilkens J, Cuypers HT, Selten G, Kroezen V, Hilgers J and Berns A. (1986). Somatic Cell & Mol. Genetics, 12, 81-88.
27. Hillion J, Mecucci C, Aventin A, Leroux D, Wlodarska I, Van den Berghe H and Larsen CJ. (1991). Oncogene, 6, 169-172.
28. Hirvonen H, Hukkanen V, Salmi TT, Makkela TP, Pelliniemi T-T, Knuutila S and Alitalo R. (1991). Blood, 78, 3012-3020.
29. Hirvonen HE, Salonen R, Sandberg MM, Vuorio E, Vastrik I, Kotilainen E and Kalimo H. (1994). Br. J. Cancer, 69, 16-25.
30. Inghirami G and Knowles DM. (1992). Neoplastic Hematopathologr, DM Knowles (ed.). Williams & Wilkins Co., pp. 27-72.
31. Jaffe ES. (1985). Surg. Path. Lymph. Organs. JL Bennington (ed.). WB Saunders Company.
32. Kantor AB and Herzenberg LA. (1993). Ann. Rev. Immunol., 11, 501-538.
33. Kineade PW and Gimble JM. (1993). Fundamental Immunology, Paul WE (ed.). Raven Press: New York. pp. 43-73.
34. Kohl NE, Gee C and Alt FW. (1984). Science, 226, 1335-1336.
35. Kung H-J and Vogt PK. (eds). (1991). Current Topics in Micro Biology and Immunol., pp. 1-172.
36. Kurie JM, Morse III H, Principato MA, Wax JS, Troppmair J, Rapp UR, Potter M and Mushinski JF. (1990). Oncogene, 5, 577-582.
37. Ladanyi M, Offit K, Parsa N, Condon MR, Chekka N, Murphy JP, Filippa DA, Jhanwar SC, Dalla-Favera R and Chaganti RS. (1992). Blood, 79, 2124-2130.
38. Langdon WY, Harris AW and Cory S. (1989). Oncogene Res., 4, 253-258.
39. Leder A, Pattengale PK, Kuo A, Stewart TA and Leder P. (1986). Cell, 45, 485-495.
40. Lee WH, Murphee AL and Benedict WF. (1984). Nature, 309, 458-460.
41. Lee WM. (1989). Cancer Treat. Res., 47, 37-71.
42. Levine PH and Hoover RN. (eds). (1992). Cancer Res. Suppl., 52, 5425-5574.
43. MacClennan ICM. (1994). Ann. Rev. Immunol. 12, 117-139.
44. Magrath I. (1992). Cancer Res., 52, 5529-5540.
45. Marin MC, Hsu B, Meyn RE, Donehower LA, El-Naggar AK and McDonnell TJ. (1994). Oncogene, 9, 3107-3112.
46. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP and Korsmeyer SJ. (1989). Cell, 57, 79-88.
47. McDonnell TJ and Korsmeyer SJ. (1991). Nature, 349, 254-256.
48. Melchers F, Hausner D, Grawunder U, Kalberer C, Karasuyama H, Winkler T and Relink AG. (1994). Ann. Rev. Immunol., 12, 209-225.
49. Mitani S, Aoki N, Mizutani S, Fujiwara M, Kitagawa T, Uehara T and Mori S. (1993). Jap. J. Cancer Res., 84, 37-41.
50. Mizukami Y, Nonomura A, Takizawa T, Noguchi M, Mishigishi T, Nakamura S and Ishizaki T. (1995). Anticancer Res., 15, 2899-2905.
51. Morgenbesser SD and DePinho RA. (1994). Semin. Cancer Biol., 5, 21-36.
52. Moroy T, Verbeek S, Ma A, Achacoso P, Berns A and Alt F. (1991). Oncogene, 6, 1941-1948.
53. Morrow MA, Lee G, Gillis S, Yancopoulos G and Alt FW. (1992). Genes and Dev., 6, 61-70.
54. Nadeau JH and Phillips SJ. (1987). Genetics, 117, 533-541.
55. Nau MM, Brooks Jr, B, Carney DN, Gazdar AF, Battey JF, Sausville EA and Minna JD. (1986). Proc. Nat. Acad. Sci., 83, 1092-1096.
56. Nisen PD, Zimmerman KA, Cotter SV, Gilbert F and Alt FW. (1986). Cancer Res., 46, 6217-6222.
57. Nunez G, London L, Hockenberry D, Alexander M, McKearn JP and Korsmeyer SJ. (1990). J. Immunol., 144, 3602-3610.
58. Osmond DG. (1990). Semin. Immunol., 2, 173-180.
59. Potter M. (1990). Carcinogenesis, 11, 1-13.
60. Price CG, Meerabux J, Murtagh S, Cotter FE, Rohatiner AZ, Young BD and Lister TA. (1991). J. Clin. Oncol., 9, 1527-1532.
61. Rajewsky K. (1996). Nature, 381, 751-758.
62. Reth MG, Ammirati P, Jackson S and Alt FW. (1985). Nature, 317, 353-355.
63. Rimokh R, Gadoux M, Bertheas MF, Berger F, Garoscio M, Deleage G, Germain D and Magaud JP. (1993). Blood, 81, 36-42.
64. Rolink A and Melchers F. (1993). Adv. Immunol., 53, 123-156.
65. Roncalli M, Viale G, Grimelius L, Johansson H, Wilander E, Alfano RM, Springall D, Battezzati PM, Polak JM and Coggi G. (1994). Cancer, 74, 134-141.
66. Rosenbaum H, Webb E, Adams JM, Cory S and Harris AW. (1989). EMBO J., 8, 7749-7755.
67. Sawyers CL, Denny CT and Witte ON. (1991). Cell, 64, 337-350.
68. Scheijen B, Jonkers J, Acton D and Berns A. (1997). J. Virol., 71, 9-16.
69. Schmidt EV, Pattengale PK, Weir L and Leder P. (1988). Proc. Natl. Acad. Sci. USA, 85, 6047-6051.
70. Schmidt T, Zornig M, Benecke R and Moroy T. (1996). Nucleic Adds Res., 24, 2528-2543.
71. Selten G, Cuypers HT, Zijlstra M, Melief C and Berns A. (1984). EMBO J., 3, 2528-3222.
72. Selten G, Cuypers HT, Boelens W, Robanus-Maandug E, Verbeek J, Domen J, van Beveren C and Berns A. (1986). Cell, 46, 603-611.
73. Sheppard RD, Montagetulli X, Jean WC, Tsai J-Y, Rose A, Guenet J-L, Cole MD and Silver LM. (1991). Mammalian Genome, 1, 104-111.
74. Shuin T, Misaki H, Kubota Y, Yao M and Hosaka M. (1994). Cancer, 73, 1721-1727.
75. Sinn E, Muller W, Pattengale PK, Teppler I, Wallace R and Leder P. (1987). Cell, 49, 465-475.
76. Smith RK, Zimmerman K, Yancopoulos G, Ma A and Alt FW. (1992). Mol. Cell. Biol., 12, 1578-1584.
77. Sole F, Woessner S, Florensa L, Perez-Losada A, Bonet C and Besses C. (1994). Cancer Genetics Cytogen., 75, 72-73.
78. Straka C, Mielke B, Eichelmann A, Trede I, Ho AD and Moller P. (1993). Leukemia, 7, 268-273.
79. Strasser A, Harris AW, Bath ML and Cory S. (1990). Nature, 348, 331-333.
80. Suda Y, Aizawa S, Hirai S, Inoue T, Furuta Y, Suzuki M, Hirohashi S and Ikawa Y. (1987). EMBO J., 6, 4055-4065.
81. Takao S, Sakai N, Aizawa S and Tokuhisa T. (1991). Kobe J. Med. Sci., 37, 227-243.
82. Tsujimoto Y, Finger LR, Yunis J, Nowell PC and Croce CM. (1984). Science, 226, 1097-1099.
83. van der Lugt NM, Domen J, Verhoeven E, Linders K, van der Gulden H, Allen J and Berns A. (1995). EMBO J., 14, 2536-2544.
84. van Lohuizen M, Verbeek S, Krimpenfort P, Domen J, Saris C, Radaszkiewicz T and Berns A. (1989). Cell. 56, 673-682.
85. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H and Berns A. (1991). Cell, 65, 737-752.
86. Vaux DL, Cory S and Adams JM. (1988). Nature, 335, 440-442.
87. Verbeck S, van Lohuizen M, van der Valk M, Domen J, Kraal G and Berns A. (1991). Mol. and Cell. Biol., 11, 1176-1179.
88. Wang J, Raffield M, Medeiros LJ, Longo DL, Jaffe ES and Stetler-Stevenson M. (1993). Leukemia. 7, 1834-1839.
89. Weiss R, Teich N, Varmus H and Coffin J. (1985). RNA tumor Viruses, Second Edition, Volumes 1 and 2. (Cold Spring Harbor Laboratory), Cold Spring Harbor, NY.
90. Wetherall NT and Vogler LB. (1992). Pathobiology, 60, 87-92.
91. Wlodarska I, Stul M, De Wolf-Peeters C, Verhoef G, Mecucci C, Cassiman JJ and Van den Berghe H. (1994). Genes, Chrom. Cancer, 10, 171-176.
92. Yano T, Jaffe ES, Longo DL and Raffeld M. (1992). Blood, 80, 758-767.
93. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theoglides A and Arnesen M. (1987). N. Eng. J. Med., 316, 79-84.
94. Zelentz AD, Chen TT and Levy R. (1990). J. Exp. Med., 173, 197-207.
95. Zimmerman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D, Gee CE, Minna JD and Alt FW. (1986). Nature, 319, 380-383.
96. Zutter M, Hockenberry D, Silverman GA and Korsmeyer SJ. (1991). Blood, 18, 1062-1068.